Cost-effectiveness of partially-hydrolyzed formula for prevention of atopic dermatitis in Australia

Journal of Medical Economics

Volumn 15, Issue 6, 2012, Pages 1064-1077

  Su, John ^a,b,c   Prescott, Susan ^d,e   Sinn, John ^f,g   Tang, Mimi ^a,b,h   Smith, Peter ⁱ   Heine, Ralf G ^a,b   Spieldenner, Jörg ^j   Iskedjian, Michael ^k,l,m  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^e PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

^f ROYAL NORTH SHORE HOSPITAL   (Australia)

^g UNIVERSITY OF SYDNEY   (Australia)

^h MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

ⁱ Queensland Allergy Services   (Australia)

^j NESTLÉ RESEARCH CENTER   (Switzerland)

^k PharmIdeas Research and Consulting Inc   (Canada)

^l PharmIdeas Europe SAS   (France)

^m UNIVERSITÉ DE MONTRÉAL   (Canada)

more..

Author keywords

Allergy; Atopic dermatitis; Cost effectiveness analysis; Economic; Infant formula; Infant nutrition; Prevention

Indexed keywords

BETAMETHASONE; BETAMETHASONE DIPROPIONATE; CEFALEXIN; CHLOROXYLENOL PLUS HYDROCORTISONE PLUS PRAMOCAINE; DERMEZE; EMOLLIENT AGENT; HYDROCORTISONE ACETATE; METHYLPREDNISOLONE ACEPONATE; PIMECROLIMUS; UNCLASSIFIED DRUG;

ARTICLE; ARTIFICIAL MILK; ATOPIC DERMATITIS; AUSTRALIA; COST EFFECTIVENESS ANALYSIS; DRUG COST; FAMILY HISTORY; HUMAN; NEWBORN; PARTIALLY HYDROLYZED INFANT FORMULA; PROPHYLAXIS;

ANIMALS; AUSTRALIA; CHILD, PRESCHOOL; COST-BENEFIT ANALYSIS; DERMATITIS, ATOPIC; GENETIC PREDISPOSITION TO DISEASE; HEALTH SERVICES; HUMANS; HYDROLYSIS; INCIDENCE; INFANT; INFANT FORMULA; INFANT, NEWBORN; MILK; MILK PROTEINS; MODELS, ECONOMETRIC; RISK FACTORS; TIME FACTORS;

EID: 84869809463     PISSN: 13696998     EISSN: 1941837X     Source Type: Journal    
DOI: 10.3111/13696998.2012.697085     Document Type: Article

References (47)

1. Spergel J, Paller A. Atopic dermatitis and the atopic march. J Allergy Clin Immunol 2003;112:S118-27
2. Asher M, Montefort S, Björkstén B, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC phases one and three repeat multicountry cross-sectional surveys. Lancet 2006;368:733-43
3. Renz H, Autenreith I, Brandtzaeg P, et al. Gene-environment interaction in chronic disease: a European Science Foundation forward look J Allergy Clin Immunol 2011;128:S27-S49
4. Prescott S, Tang M. The Australasian Society of Clinical Immunology and Allergy position statement: summary of allergy prevention in children. Med J Aust 2005;182:464-7
5. World Health Organization, United Nations Children's Fund. Global strategy for infant and young child feeding. Geneva: NLM Classification; WS 120,2003
6. World Health Organization. World Health Organization's recommendations on breasfeeding. http://www.who.int/topics/breastfeeding/en. Accessed September 19, 2012
7. Boyce J, Assaa'ad A, Burks A, et al. Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAIDSponsored Expert Panel. J Allergy Clin Immunol 2010;126:S1-S58
8. Greer F, Sicherer S, Burks A. Effects of early nutritional interventions on the development of atopic disease in infants and children: the role of maternal dietary restriction, breasfeeding, timing of introduction of complementary foods, and hydrolyzed formulas. Pediatrics 2008;121:183-91
9. Høst A, Halken S, Muraro A, et al. Dietary prevention of allergic diseases in infants and small children. Amendment to previous published articles in Pediatric Allergy and Immunology 2004, by an expert group set up by the Section on Pediatrics, European Academy of Allergology and Clinical Immunology. Pediatr Allergy Immunol 2008;19:1-4
10. Baehler P, Baenziger O, Belli D, et al. Empfehlungen für die Säuglingsernährung 2009. Paediatrica 2009;20:13-15
11. Chouraqui J-P, Dupont A, Bocquet A, et al. Alimentation des premiers mois de vie et prevention de l'allergie (Feeding during the first months of life and prevention of allergy). Arch Pédiatr 2008;15:431-42
12. Dalmau Serra J, Martorell Aragonés A. Alergia a proteínas de leche de vaca: prevención primaria. Aspectos nutricionales. Anal Pediatr 2008;68:295-300
13. Muche-Borowski C, Kopp M, Reese I, et al. Allergieprävention. 2009. Report No.: AWMF Guideline Register 061/16
14. Exl B-M. A review of recent developments in the use of moderately hydrolyzed whey formulae in infant nutrition. Nutr Res 2001;21:355-79
15. von Berg A, Koletzko S, Filipiak-Pittroff B, et al. The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: The German Infant Nutritional Intervention Study, a randomized double-blind trial. J Allergy Clin Immunol 2003;111:533-40
16. von Berg A, Filipiak-Pittroff B, Krämer U, et al. Preventative effect of hydrolyzed formulas persists until age 6 years: long-term results from the German Infant Nutritional Intervention Study (GINI). J Allergy Clin Immunol 2008;121:1442-7
17. von Berg A, Koletzko S, Filipiak-Pittroff B, et al. Certian hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three-year results of the German Infant Nutritional Intervention Study. J Allergy Clin Immunol 2007;119:718-25
18. Szajewska H, Horvath A. Meta-analysis of the evidence for a partially hydrolyzed 100% whey formula for the prevention of allergic diseases. Curr Med Res Opin 2010;26:423-37
19. Alexander D, Cabana M. Partially hydrolyzed 100% whey protein infant formula and reduced risk of atopic dermatitis: a meta-analysis. J Pediatr Gastroenterol Nutr 2010;50:422-30
20. Lewis-Jones S. Quality of life and childhood atopic dermatitis: the misery of living with childhood eczema. Int J Clin Pract 2006;60:984-92
21. Kemp A. Atopic eczema: its social and financial costs. J Paediatr Child Health 1999;35:229-31
22. Su J, Kemp A, Varigos G, et al. Atopic eczema: its impact on the family and financial cost. Arch Dis Child 1997;76:159-162
23. Iskedjian M, Dupont C, Kanny G, et al. Economic evaluation of a 100% wheybased, partially hydrolyzed formula in the prevention of atopic dermatitis among French children. Curr Med Res Opin 2010;26:2607-26
24. Iskedjian M, Haschke F, Farah B, et al. Economic evaluation of a 100% whey-based partially hydrolyzed infant formula in the prevention of atopic dermatitis among Danish children. J Med Econ 2011;15(2):394-408
25. Iskedjian M, Belli D, Farah B, et al. Economic evaluation of a 100% whey-based partially hydrolyzed infant formula in the prevention of atopic dermatitis among Swiss children. J Med Econ 2011;15(2):378-393
26. Iskedjian M, Szajewska H, Spieldenner J, et al. Extension of a meta-analysis of the evidence for a partially hydrolyzed 100%-whey formula in the prevention of atopic dermatitis: brief research report. Curr Med Res Opin 2010;26:2599-606
27. Australian Bureau of Statistics. Number of Births in Australia in 2009. http:// www.abs.gov.au/ausstats/abs@nsf/Products/F57D30403E4EBD9BCA2577 CF000DEFBD?opendocument. Accessed January 11, 2012
28. Australian Institute of Family Studies. Annual Report 2006-2007 - Breasfeeding. http://www.aifs.gov.au/growingup/pubs/ar/ar200607/breastfeeding. html. Accessed: January 11, 2012
29. Bergmann R, Edenharter G, Bergmann K, et al. Atopic dermatitis in early infancy predicts allergic airway disease at 5 years. Clin Exp Allergy 1998;28:965-70
30. Halken S. Allergy Review Series VI: the immunology of fetuses and infants. The lessons of noninterventional and interventional prospective studies on the development of atopic disease during childhood. Allergy 2000;55:793-802
31. Australian Bureau of Statistics. Deaths in Austrlia, 2009 - Life Tables (Tables 4.1 and 4.2). http://www.abs.gov.au/ausstats/abs@nsf/Products/ 381E296AFC292B6CCA2577D60010A095?opendocument. Accessed January 11, 2012
32. Australian Government Department of Health and Ageing. Medicare Benefits Schedule Book - Operating from 01 January 2012. http:// www.health.gov.au/ internet/mbsonline/publishing.nsf/Content/678D016AC 77C6767CA2579500078C094/ $File/201201-Cat%202.pdf. Accessed January 11, 2012
33. Pharmacy Direct. Emollient cost. http://www.pharmacydirect.com.au/ product-details.aspx?invpid=018079. Accessed January 11, 2012
34. Australian Government Department of Health and Ageing. Pharmaceutical Benefits Scheme (PBS). http://www.pbs.gov.au/pbs/home. Accessed January 11, 2012
35. Australian Government - Medicare Australia. Explanation of Pharmaceutical Benefits Scheme (PBS) Pricing. http://www.medicareaustralia.gov.au/ provider/pubs/program/files/2526-explanation-of-pbs-pricing.pdf. Accessed January 11, 2012
36. Barozzi N, Sketris I, Cooke C, et al. Comparison of nonsteroidal anti-inflammatory and cyclooxygenase-2 (COX-2) inhibitors use in Australia and Nova Scotia (Canada). Br J Clin Pharmacol 2009;68:106-15
37. Australian Bureau of Statistics. Australia - 2006 Census of Population and Housing - Age (Full classification list) by sex - (Cat. No. 2068.0). http://www.censusdata.abs.gov.au/ABSNavigation/prenav/ViewData?method= Placeof%20Usual%20Residence&subaction=-1&producttype= Census%20Tables&areacode=0&order=1&productlabel= Age%20(full%20classification%20list)%20by%20Sex%20&tabname= Details&action=404&documenttype-Details&collection= Census&textversion=false&breadcrumb=TLPD&period=2006&issue= 2006&javascript=true&navmapdisplayed=true&documentproductno=0&. Accessed January 11, 2012
38. Australian Bureau of Statistics. Labour force in Austrlia. 2011. http:// www.abs.gov.au/ausstats/abs@nsf/mf/6202.0. Accessed January 11, 2012
39. International Labour Organization. Hours of work per week by economic activity in Australia in 2008 (Table 4A). http://laborsta.ilo.org/. Accessed January 11, 2012
40. International Labour Organization. Wages by economic activity in Australia in 2006 (Table 5A). http://laborsta.ilo.org/. Accessed January 11, 2012
41. New South Wales Government. Maximum taxi fares and charges for 2011. http://www.transport.nsw.gov.au/content/maximum-taxi-fares-and-charges. Accessed January 11, 2012
42. New South Wales Government-Transport Info. All fares (transport info). http:// www.131500.com.au/tickets/fares/all-faresmybus. Accessed January 11, 2012
43. State Government of Victoria A. Taxi fares in Victoria. http://www. transport.vic.gov.au/taxis/customers/taxi-fares-in-victori.a. Accessed January 11, 2012
44. State Government of Victoria A. Myki metro fares 2012. http://www.myki. com.au/Fares/Metro-fares-/2012-Metro-fares. Accessed January 11, 2012
45. Australian Government Department of Health and Ageing. Guidelines for preparing submissions to the Pharmaceutical Benefits Advisory Committee (Version 4.3). 2008. http://www.health.gov.au/internet/main/publishing. nsf/content/AECB791C29482920CA25724400188EDB/$File/PBAC4.3.2. pdf. Accessed January 11, 2012
46. Osborn DA, Sinn JKH. Formulas containing hydrolysed protein for prevention of allergy and food intolerance in infants. Cochrane Database of Systematic Reviews 2006, Issue 4. Art. No.: CD003664. DOI: 10.1002/ 14651858.CD003664.pub3.
47. Briggs A, Clarxton K, Sculpher M. Decision modeling for health economic evaluation. Oxford, UK: Oxford University Press, 2008